Bladder Cancer - Results from #60

REVIEW UroToday

Bacillus Calmette-Guerin (BCG) Vaccine Impact on Dementia Risk in Bladder Cancer Patients: A Systematic Review and Meta-Analysis. October 3, 2024

Characterizing Psychological Resources and Resilience in Patients With Bladder Cancer: Associations With Frailty and Quality of Life. October 2, 2024

Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy. October 2, 2024

Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients. October 1, 2024

Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC): Considerations from the European Association of Urology NMIBC Guideline Panel. October 1, 2024

Prognostic Nomogram, Demographics and Comparative Analysis of Urinary Bladder Small Cell and Large Cell Neuroendocrine Carcinoma. October 1, 2024

Adjuvant radiation therapy for locally advanced bladder cancer: A safe and promising emerging treatment option September 30, 2024

Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs September 30, 2024

Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value. September 30, 2024

Risk of Progression of High-grade Primary T1 Non-muscle-invasive Bladder cancer in a Contemporary Cohort. September 30, 2024

MTAP protein status is highly concordant with CDKN2A fluorescent in situ hybridization and allows stratification of the luminal subtype in muscle-invasive bladder cancer. September 30, 2024

Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer. September 30, 2024

Real-word outcomes for high-risk non-muscle-invasive bladder cancer: screened patients for the BRAVO trial. September 27, 2024

Bladder cancer incidence and mortality among men with and without castration therapy for prostate cancer - a nation-wide cohort study. September 27, 2024

Improved bladder diagnostics using multiparametric ultrasound. September 27, 2024

The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee. September 26, 2024

An overview of immune checkpoint inhibitor toxicities in bladder cancer. September 26, 2024

Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States. September 25, 2024

Clinical use of nadofaragene firadenovec-vncg. September 25, 2024

Basal/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial. September 24, 2024

Page 4 of 517